Insider · CIK 0001235685
Agnes Rey-Giraud
Files at UPH (UpHealth, Inc.), GDRX (GoodRx Holdings, Inc.). First filing -, latest -.
In brief
Agnes Rey-Giraud files SEC Form 4 as director at UPH (UpHealth, Inc.), and also at GDRX (GoodRx Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Agnes Rey-Giraud has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | GDRX GoodRx Holdings, Inc. | AGrant or award Class A Common Stock | +73,434 | $0.00 | $0 | 426,286 | Jun 17, 2026 |
| Mar 12, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Class A Common Stock | +192,185 | $0.47 | $90k | 277,633 | Mar 13, 2026 |
| Mar 12, 2026 | GDRX GoodRx Holdings, Inc. | GGift Class A Common Stockindirect: By ARG Family Legacy Trust #1 | -75,219 | $0.00 | $0 | 0 | Mar 13, 2026 |
| Mar 12, 2026 | GDRX GoodRx Holdings, Inc. | GGift Class A Common Stock | +75,219 | $0.00 | $0 | 352,852 | Mar 13, 2026 |
| Mar 12, 2026 | GDRX GoodRx Holdings, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -192,185 | $0.00 | $0 | 0 | Mar 13, 2026 |
| Aug 18, 2025 | GDRX GoodRx Holdings, Inc. | GGift Class A Common Stock | -75,219 | $0.00 | $0 | 85,448 | Aug 19, 2025 |
| Aug 18, 2025 | GDRX GoodRx Holdings, Inc. | GGift Class A Common Stockindirect: By ARG Family Legacy Trust #1 | +75,219 | $0.00 | $0 | 75,219 | Aug 19, 2025 |
| Jun 3, 2025 | GDRX GoodRx Holdings, Inc. | AGrant or award Class A Common Stock | +57,050 | $0.00 | $0 | 160,667 | Jun 4, 2025 |
| Jan 31, 2024 | UPH UpHealth, Inc. | AGrant or award Common Stock | +100,000 | $0.00 | $0 | 114,405 | Feb 2, 2024 |
Questions about Agnes Rey-Giraud
Answered from the filings on this page, as of the latest one.
Is Agnes Rey-Giraud buying or selling?
Agnes Rey-Giraud has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Agnes Rey-Giraud's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Agnes Rey-Giraud has 0.
Where does Agnes Rey-Giraud file Form 4?
Agnes Rey-Giraud has filed Form 4 at UPH (UpHealth, Inc.); GDRX (GoodRx Holdings, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.